Zoldro 4 mg consists of an active ingredient, zoledronic acid. It belongs to the group of substances called bisphosphonates. It is used to reduce the amount of calcium in the blood in people where it is too high due to cancer or any other condition. The main function of this injection is to increase bone density.
Key Features
| About Product | |
|---|---|
| Product Name | Zoldro 4 mg |
| Drug Class | Organic phosphonic acids and derivatives |
| Chemical Class | Bisphosphonates |
| Product Details | |
|---|---|
| Active Ingredient | Zoledronic Acid |
| Formulation | Intravenous Preparation |
| Dosage | 4 mg |
| Uses | Osteoporosis |
| Onset of Action | 1–2 Hours |
| Duration of Action | 1–2 Years |
| Manufacturer | United Biotech Pvt. Ltd. |
| Shelf Life | 2 Years |
| Country of Origin | India |
| Storage | Store Below 77℉ |
How does Zoldro 4 mg work?
Zoldro 4 mg consists of zoledronic acid which works by inhibiting osteoclast activity. The drug slows down the rate of resorption of the bone cells, giving them enough time to grow on their own.
Directions for use
The injection is delivered through an intravenous method. It should never be self-administered. It is generally administered within 3-4 weeks.
Dosage
Use as and when prescribed by the healthcare provider.
Uses
Zoldro 4 mg can be used for:
- Osteoporosis
- Paget’s disease of bone
- Cancer related bone complications
- Hypercalcemia of malignancy
Side effects
Some major and minor side effects seen with Zoldro 4 mg are:
- Abdominal pain
- Acid reflux
- Headache
- Muscle or Joint pain
- Flatulence
- Diarrhea
- Constipation
- Difficulty in swallowing
- Diarrhea
- Pain at the injection site
Interactions
Drug-drug Interactions
- Concomitant use of nephrotoxic drugs along with Zoldro 4 mg can increase the risk of kidney dysfunction.
- Using loop diuretics like furosemide, bumetanide, etc along with zoledronic acid can increase the risk of developing severe, symptomatic hypocalcemia.
- Using aminoglycoside antibiotics with the injection can be risky as it can lower the levels of calcium in the blood.
- Do not administer zoledronic acid along with other bisphosphonates or RANKL inhibitors (e.g. denosumab) without medical supervision.
Drug-disease interaction
- Zoldro 4 mg should be used with extreme caution or avoided in patients with severe kidney disease or impaired creatinine clearance.
- The injection should be avoided in patients with pre-existing calcium levels until the condition is corrected.
- Clinical monitoring is required for asthma-sensitive asthma patients.
Precautions & Warnings
- Do not use the injection if you are allergic to Zoledronic acid or any other ingredient of the injection
- Strict monitoring and specific safety precautions should be followed
- It is generally unsafe during pregnancy and breast feeding as it can cause fetal harm.
- Do not drive or operate heavy machineries until you know how the medication affects your body.
- It is generally advised to avoid alcohol or limit during the treatment.
- Zoldro 4 mg is contraindicated in patients with low levels of calcium in their blood and with a high level of kidney damage.
- It is not advised to be used in children and adolescents under 18 years of age.
Conclusion
Zoldro 4 mg is an intravenous bisphosphonate medication containing zoledronic acid, primarily used to treat osteoporosis, especially in postmenopausal women and individuals receiving long-term steroid therapy. It also plays a vital role in managing high calcium levels caused by certain cancers, Paget’s disease of bone, etc. Patients should follow their healthcare provider’s recommendations regarding dosage, monitoring, and follow-up care.
hazel adams –
The injection worked effectively and the treatment went smoothly.